Skip to main content

Defining the Radiological Blinded Read and Adjudication

  • Chapter
  • First Online:
Medical Imaging in Clinical Trials

Abstract

The term blinded read or independent read is used in literature to define a process by which medical images are read by an independent radiologist or team of radiologists and or physicians. There are three major kinds of blinded read: eligibility, safety, and efficacy, of which each of these is managed in a different manner. This chapter presents the various methodologies that are employed in blinded reads across phases of trials and between different therapeutic areas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amit O, Bushnell W, Dodd L, et al. Blinded independent central review of the progression-free survival endpoint. Oncologist. 2010;15:492–5.

    Article  PubMed  Google Scholar 

  2. Amit O, Mannino F, Stone AM, et al. Blinded independent central review of progression in cancer clinical trials: results from a meta-analysis. Eur J Cancer. 2011;47:1772–8.

    Article  CAS  PubMed  Google Scholar 

  3. Dodd LE, Korn EL, Freidlin B, et al. Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense? J Clin Oncol. 2008;26:3791–6.

    Article  PubMed  Google Scholar 

  4. Meignan M, Itti E, Bardet S, et al. Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials. J Clin Oncol. 2009;27:2739–41.

    Article  PubMed  Google Scholar 

  5. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.

    Article  CAS  PubMed  Google Scholar 

  6. van der Heijde D, Dankert T, Nieman F, et al. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford). 1999;38:941–7.

    Article  Google Scholar 

  7. Landewe R, Van Der Heijde D. Radiographic progression in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23:S63–8.

    PubMed  Google Scholar 

  8. Miller CG. Medical imaging core laboratories. Appl Clin Trials Acts. 2005. Available at: http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/article/articledetail.jsp?id=182766&pageid=2.

  9. Berland LL, Silverman SG, Gore RM, et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol. 2010;7:754–73.

    Article  PubMed  Google Scholar 

  10. Berlin L. The incidentaloma: a medicolegal dilemma. Radiol Clin North Am. 2011;49:245–55.

    Article  PubMed  Google Scholar 

  11. Booth TC, Waldman AD, Wardlaw JM, et al. Management of incidental findings during imaging research in “healthy” volunteers: current UK practice. Br J Radiol. 2012;85:11–21.

    Article  CAS  PubMed  Google Scholar 

  12. Lumbreras B, Donat L, Hernandez-Aguado I. Incidental findings in imaging diagnostic tests: a systematic review. Br J Radiol. 2010;83:276–89.

    Article  CAS  PubMed  Google Scholar 

  13. Morris Z, Whiteley WN, Longstreth WT, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Orme NM, Fletcher JG, Siddiki HA, et al. Incidental findings in imaging research: evaluating incidence, benefit, and burden. Arch Intern Med. 2010;170:1525–32.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Siddiki H, Fletcher JG, Mcfarland B, et al. Incidental findings in CT colonography: literature review and survey of current research practice. J Law Med Ethics. 2008;36:320–31.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357:1821–8.

    Article  CAS  PubMed  Google Scholar 

  17. Wolf SM, Paradise J, Caga-Anan C. The law of incidental findings in human subjects research: establishing researchers’ duties. J Law Med Ethics. 2008;36:361–83.

    Article  PubMed Central  PubMed  Google Scholar 

  18. FDA. Guidance for industry standards for clinical trial imaging endpoints. 2011. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM268555.pdf.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Colin G. Miller BSc, PhD, FICR, CSci .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Miller, C.G. (2014). Defining the Radiological Blinded Read and Adjudication. In: Miller, C., Krasnow, J., Schwartz, L. (eds) Medical Imaging in Clinical Trials. Springer, London. https://doi.org/10.1007/978-1-84882-710-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-710-3_5

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-709-7

  • Online ISBN: 978-1-84882-710-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics